Supplementary Figure 5 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Authors:
- Dian KortleveDKDian Kortleve
- Dora HammerlDHDora Hammerl
- Mandy van BrakelMBMandy van Brakel
- Rebecca WijersRWRebecca Wijers
- Daphne RoelofsDRDaphne Roelofs
- Kim KroeseKKKim Kroese
- Mieke M. TimmermansMTMieke M. Timmermans
- Chen-Yi LiaoCLChen-Yi Liao
- Shaozhuo HuangSHShaozhuo Huang
- Anita Trapman-JansenATAnita Trapman-Jansen
- Renée FoekensRFRenée Foekens
- Justine MichauxJMJustine Michaux
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)